Healthcare Triangle Pursues Up to $30 Million Roboticom Asset Deal

Sep 23, 2026
Healthcare Triangle signed a nonbinding letter of intent with Crestpoint Capital to acquire intellectual property, contracts, trademarks and other assets associated with industrial robotics provider Roboticom.

Healthcare Triangle, Inc. signed a nonbinding letter of intent with Crestpoint Capital for a potential acquisition of assets associated with Roboticom, the company announced in a press release. The proposed transaction covers customer contracts, intellectual property, trademarks and other business assets for up to $30 million in cash and equity paid over time.

Roboticom, based in Pisa, Italy, provides industrial robotic automation systems for aerospace, marine, automotive, composites, manufacturing, orthotics and prosthetics customers. Its products include the SandRob, ORTIS and ScultoRob lines. Healthcare Triangle plans to combine its AI, cloud and data technology with the robotics platform.

Roboticom's owners reported unaudited fiscal 2025 revenue of about $14.1 million and gross margin of $6.9 million. The letter of intent is not binding, and completion depends on due diligence, audited financial statements, financing, approvals and definitive agreements.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Robotics Brief, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

AI & Robotics AI Funding News AI Brief AI Brief (X)
Free newsletter

AI Funding Brief

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.